Structure and polymorphism of solid pharmaceutical substances
Transcript of Structure and polymorphism of solid pharmaceutical substances
![Page 2: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/2.jpg)
2
Content
Cocrystal, pharmaceutical cocrystal – definition
Pharmaceutical cocrystal proccesing
Why cocrystals are interesting for pharmacy
Cocrystal classification
Cocrystal desing
Cocrystal partners (active substances and coformers)
Cocrystal prediction
Cocrystal preparation strategy
Cocrystal analytics
Conclusion
![Page 3: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/3.jpg)
Crystalline Multi-Component compounds
3
The charming word "cocrystal" was first used at work:Hoogsteen K.: Crystal and Molecular Structure of a Hydrogen-BondedComplex Between 1-Methylthymine and 9-Methyladenine. Acta Crystallogr. 16, 907 (1963).
Crystalline Multi-Component compounds have very branchedterminology: … mixed crystals, clathrates, inclusion compounds, organic molecular compounds, molecular complexes, heteromolecularcrystals, supramolecular adducts… and cocrystals (co-crystals)
A co-crystal is not a mixture, but a new chemical entity !
The first prepared mixed crystal (cocrystal) was quinhydrone, studied by Friedrich Wöhler in 1844. Quinhydrone is a cocrystal of quinoneand hydroquinone (known archaically as quinol). He found that this material was made up of a 1:1 molar combination of the components.
![Page 4: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/4.jpg)
Cocrystals
4
Definition: cocrystals are solids that are crystalline single phase materials composed of two or more different molecular or ionic compounds generally in a stoichiometric ratio which are neither solvates nor simple salts
Cocrystal applications- Optical or photo-responsive materials (aminopyrazine with boric acid)- Medicine and energetics (nano-cocrystals)- Agrochemicals and pigments- API in pharmacy (pharmaceutical cocrystal)
A pharmaceutical cocrystal, definition: a stoichiometric multicomponent host-guest compound (host = active molecule, guest = cocrystallization former, coformer1) formed from two or more components that are solid in a pure state and at room temperature2. The host-guest stoichiometric ratio is mostly simple (1:1, 2:1, 3:1, 4:1, and 1:4, respectively). Eg. Carbamazepine : 4-aminobenzoic acid cocrystal system, can exist in 1:1, 2:1, and 4:1 stoichiometric configurations.
1. Even the coformer may be an active molecule, e.g. cocrystal theophylline:nicotinamide (1:1). 2. Aakeröy C.B., Salmon D.J.: CrystEngCommun. 7, 439 (2005).
![Page 5: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/5.jpg)
5
Pharmaceutical cocrystal – an example
Cocrystal carmabazepine: saccharin (1:1)
(carbamazepine forms with different coformers about 50 cocrystals)
![Page 6: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/6.jpg)
Cocrystal carbamazepine : saccharine (1:1)
How cocrystals held together
- - -
Zaworotko M.: Crystal engineering of cocrystals and their relevance to pharmaceutical and solid state chemistry. IUCr2008, KN32. Osaka 2008.
H-bonds H-bonds H-bonds H-bonds
The molecules in co-crystals retain their covalent identity
6
![Page 7: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/7.jpg)
7
Cocrystal processing – a beginning of the story
1) Syntetic and crystallographic epoch, academics (1963 – 2000)
Hoogsteen K.: Cocrystal of 1-methylthimine and 9-methyladenine. Acta Crystallogr. 16, 907 (1963).
2) Study of cocrystal application in pharmacy, patents (2000 – today)
3) Regulatory Classification of Pharmaceutical Co-Crystals. Guidance for Industry (February 2018). U.S. Department of Health and Human Services Food and Drug
Administration Center for Drug Evaluation and Research (CDER) Pharmaceutical Quality/CMC.
Cocrystals were finally and oficially recognized by FDA in 2018, as a new broad class of APIs
![Page 8: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/8.jpg)
Cocrystal patents
8
Trend of co(−)crystals in WIPO patent database from 2004 until December 2017
Maryam Karimi-Jafari, Luis Padrela Gavin M. Walker, Denise M. Croker:Creating Cocrystals: A Review of Pharmaceutical Cocrystal Preparation Routes and ApplicationsCrystal Growth & Design2018 18 (10), 6370-6387.
![Page 9: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/9.jpg)
9http://www.mhra.gov.uk/spc-pil/?subsName=AGOMELATINE%20/%20CITRIC%20ACID%20CO-CRYSTAL&pageID=SecondLevel
Co-crystals in medical practice
![Page 10: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/10.jpg)
Chemical and physical forms of solid APIs
So, pharmacy has hundreds of possible solid APIs (from onemolecule) available for drug formulation development
10
![Page 11: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/11.jpg)
Criteria of the optimal API choice for solid dosage form
Functional, technological, commercial and legal aspects
A patient uses no separated molecule, but solid state !
Terapeutical (biological) activitySolubility, dissolution rate,
permeability, bioavailability
Stability (chemical and physical)Robustness and reproducibility of
manufacture
Chemical and physical purity Resistance to mechanical stress
Hygroscopicity Processability
Choice of crystalline or amorphous
phasesDose amount
Tendency to polymorphism Taste acceptability
Compatibility with excipientsPossibility of corrosion of production devices
Toxicity Patent collision
J.BudkaJ.Budka
11
![Page 12: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/12.jpg)
12
Some well-known pharmaceutical cocrystals
Active molecule : coformer
carbamazepine : saccharine carbamazepine : nicotinamidepiroxicam : sodium acetateitraconazole : L-tartaric acid itraconazole : succinic acid norfloxacin : isonicotinamideibuprofen : nicotinamidetrospium chloride : ureacelecoxib : nicotinamideagomelatine : hydroquinonemelamine : cyanuric a.
Cocrystals are not pharmacodynamically more effective than pure (parent) active substance itself, but they modify (optimize) its technological or function parameters, eg. solubility, dissolution profile, oral bioavailability, physical and chemical stability, hygroscopicity, flow properties, mechanical properties, etc .
Active molecule : coformer
etravirine : nicotinamideparacetamol : theophylinequercetin : caffeinesildenafil : acetylsalicylic acidmirtazapin : dicarboxilic acidsmyricetin : 4,4′-bipyridinefurosemide : picolinamdeaspirin : 4,4′-bipyridine5-fluorouracil : ureaivabradine hydrochloride (S):mandelic acid
![Page 13: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/13.jpg)
Why cocrystals are interesting for pharmacy –examples
Active substance Cocrystal Cocrystal parameters
ibuprofen ibuprofen : nicotinamide lower hygroscopicity
indomethacin indomethacin : saccharine better dissolution rate
norfloxacin norfloxacin : isonicotinamide
norfloxacin : succinic a. (or malonic a.)
better solubility,
better crystal shape
caffeine caffeine : malonic a. no hydrates are formed at
the high relative humidity
paracetamol paracetamol : theophyline (or
napthalene)
better tablet strength
carbamazepine carbamazepine : saccharin no polymorphs or
hydrates are formed
hydrochlorothiazide hydrochlorothiazide : sucralose taste masking
13
![Page 14: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/14.jpg)
Why cocrystals are interesting for pharmacy ?
Amorphous itraconazole (API) Sporanox® (Salutas Pharma), antifungal drug
The first case study – modification of the dissolutin profile
Cocrystals of itraconazole with 1,4-dicarboxylic acids:
L-malic, L-tartaric and succinic
Example: cocrystal of itraconazole with succinic acid (2:1)
„sandwich structure“
14
![Page 15: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/15.jpg)
Cocrystals can modify dissolution profile
Morissete S.L. et al.: Advaced Drug Delivery Reviews 56, 275 (2004).
itraconazole amorphatecocrystal itraconazole : L- malic acid (2:1)
cocrystal itraconazole : L- tartaric acid (2:1)cocrystal itraconazole : succinic acid (2:1)
itraconazole crystalline
15
PICO – picolinic a.NICO – nicotinamideCAFF – caffeine
Chadha, K.; Karan, M.; Bhalla, Y.; Chadha, R.; Khullar, S.; Mandal, S.; Vasisht, K. Cocrystals of Hesperetin: Structural, Pharmacokinetic, and Pharmacodynamic Evaluation. Cryst. Growth Des. 2017, 17 (5), 2386–2405.
![Page 16: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/16.jpg)
Cocrystallization of trospium chloride with urea
Trospium chloride –urinary antispasmodic
Urea
Cocrystal trospium chloride : urea (1:1)
Crystal structure of cocrystal 16
![Page 17: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/17.jpg)
Cocrystallization of trospium chloride with urea
1. Skořepová, E., Čejka, J., Hušák, Eigner, V., Rohlíček, J., Šturc, A., Kratochvíl, B.: TrospiumChloride: Unusual Example of Polymorphism Based on Structure Disorder. Cryst. Growth Des. 13, 5193–5203 (2013).
2. Sládková V., Cibulková J., Eigner V., Šturc A., Rohlíček J., Kratochvíl B.: Application and Comparison ofCocrystallization Techniques on Trospium Chloride Cocrystals. Cryst. Growth Des. In print (2014).
3. Skořepová E., Hušák M., Čejka J., Zámostný P., Kratochvíl B.: Increasing dissolution of trospium chloride by co-
crystallization with urea. J. Cryst. Growth 399, 19-26 (2014).
Modification of the dissolution profile
17
Trospium chloride
![Page 18: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/18.jpg)
Why cocrystals are interesting for pharmacy ?
The second case study – bypassing the problem of polymorphism
N
NH2O
Carbamazepine (crystalline API), dosage form Tegretol®,(Novartis), anticonvulsant
Carbamazepine has bad properties:
polymorphic molecule – 4 polymorphs are described
forms several solvates and hydrates
bad dissolution profile
18
![Page 19: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/19.jpg)
Cocrystal of carbamazepin : saccharin (1:1) solves a polymorphism problem
N
NH2O
NHS
O
OO
Crystal structure of one carbamazepine polymorphs
Crystal structure of cocrystal carbamazepine : saccharine (1:1)
:
This cocrystal is monomorphic and no its solvates or hydrates are known
Fleischman G.S. et al.: Crystal Growth & Design. 3, 909–919 (2003).19
![Page 20: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/20.jpg)
The third case study – the separating cocrystallization
Samas B. et al.: Acta Crystallogr. E63, 3938 (2007).
pregabalin (API)
dosage form Lyrica®,(Pfizer),
anticolvulsant
Crystal structure of the cocrystal
(S)-pregabalin : (S)-mandelic a. (1:1)
Cocrystallization of pregabalin with (S)-mandelic acid separates only (S)-pregabalin from racemic mixture
Why cocrystals are interesting for pharmacy ?
(S)-pregabalin
20
![Page 21: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/21.jpg)
The forth case study – improving of mechanical properties
Why cocrystals are interesting for pharmacy ?
Paracetamol (analgesic and antipyretic API)
Polymorph I – stable for dosage formulation
Polymorph II - unstable Polymorph III - unstable
Jones W.: 25.European Crystallographic Meeting. Istanbul 2009.
paracetamolpolymorph I
paracetamol:theophyline (1:1)
paracetamol:napthalene (2:1)
paracetamol:oxalic a. (1:1)
paracetamol:phenantroline (1:2)
Paracetamol cocrystals have better tablet strength than pure paracetamol polymorph I
21
![Page 22: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/22.jpg)
Cocrystal classification (nomenclature)
Cocrystals (binary, ternary, quarternary …) Cocrystals solvated (hydrated) Cocrystals of salts (ionic cocrystals) Cocrystals of salts solvated (hydrated) Cocrystal polymorphism (packing and conformational)
ko, ko, ko ….22
![Page 23: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/23.jpg)
Binary and higher cocrystals
Binary cocrystal
Quarternary cocrystal
Ternary cocrystal
Bhogala B.R. et al.: New J. Chem. 32, 800 (2008).
H3CTA
bipy H3CTA
H3CTAH3CTA
H3CTA
bipy
H3CTAH3CTA
H3CTA
H3CTAbipy-etabipy-Brete
bipy-diBreta
bipy-eta
H3CTA – cyklohexantricarboxylic a.bipy - bipyridine
23
![Page 24: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/24.jpg)
Cocrystal solvated
Solvated cocrystal - cocrystal contains a component that isliquid at room temperature
Cocrystal norfloxacin : isonicotinamide : chlorophorm (1:1:1)
isonicotinamidenorfloxacin (antibacterial agent)
chlorophorm
H-bond
Basavoju S., Boström D., Velaga S.P.: Crystal Growth & Design 6, 2699-2708 (2006).24
![Page 25: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/25.jpg)
25
Cocrystal hydrated
theophylline citric acid
water
Cocrystal theophylline : citric acid : water (1:1:1)
Lange L., Sadowski G.: Crystal Growth & Design 16, 4439-4449 (2016).
![Page 26: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/26.jpg)
When free acids, free bases or neutral molecules have available
free H-donors or H-acceptors form stable hydrates
Why form molecules hydrates ?
dipicolinic acid proton acceptor available
proton acceptor available
proton acceptor available
Anhydrate (unstable)
Hydrate is more stable (all H-donors and H-acceptors are involved in H-bonding)
All good proton donors and acceptors are used in hydrogen bonding (Etter‘s rule)
26
Hydrate (stable)
![Page 27: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/27.jpg)
Ionic cocrystals (cocrystals of salts)
fluoxetine hydrochloride (antidepresivum), Prozac® (Eli Lilly)
fluoxetine hydrochloride : benzoic acid (1:1)
fluoxetin hydrochloride : succinic acid (2:1) fluoxetine hydrochloride : fumaric acid (2:1)
Childs S.L. et al.: J. Amer. Chem. Soc. 126, 13335 (2004).
Host is the pharmaceutical salt – fluoxetine hydrochloride
ionic cocrystals
ionic cocrystals ionic cocrystals
salt
27
![Page 28: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/28.jpg)
caffeine
N
NN
N
O
O OH O
OHO
glutaric acid
+
Cocrystal caffeine : glutaric a. (1:1)
Trask A.V. et al.: Chem. Commun. 2004, 890.
cyclohexane chlorophorm
Cocrystal conformational polymorphism
polymorf I
polymorf II
„”Every compound has different polymorphic forms and that, in general, the number of forms known for a given compound is proportional to the time & energy spent in research on that compound”
Walter McCrone, 1963
Dropping solvent
polymorf I polymorf II
Conformational polymorphism
(liquid-assisted grinding)
28
![Page 29: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/29.jpg)
29
Cocrystal packing polymorphism
Two polymorphs of cocrystal caffeine (blue) : theophyline (green)
Two polymorphs of cocrystal urea (green) : 4, 4‘ - bipyridine (blue)
![Page 30: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/30.jpg)
Salts vs. cocrystals - where is the border between them
Cocrystal dihydrogenphosphate of „active molecule“ : phosphoric acid (1:1)
proton stays on the acid: H3PO4proton moves to nitrogen: H2PO4
–
Crystallization of „active molecule“ withtwo molecules of phosphoric acid – twodifferent bond situations
Chen M.A. et al.: Chem. Commun. (2007) 419.
O1 O2
Different character of two phosphoric acid molecules in cocrystal
„active molecule“
phosphoric a.
30
![Page 31: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/31.jpg)
Boundary line between cocrystal and salt
The reaction between carboxylic acid and basic heterocycleExample: benzoic acid + 3,5-dichlorpyridine ?
3,5-dichlorpyridinium benzoate or ? cocrystal 3,5-dichlorpyridine : benzoic a. (1:1)
Salt (yes, proton transfer) Cocrystal (no proton transfer)
Direct determination of H-position: high-quality of X-ray single crystal data, NMR, neutron diffraction, photoelectron spectroscopy (XPS), Undirect determination of H-atom position: X-ray diffraction (from bond lenghts C-O and angles O-C-O)
Position of hydrogen atom (proton resp.) determines if salt or cocrystal is formed
1Å1Å
1,5 Å1,5 Å
31
![Page 32: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/32.jpg)
32
Skořepová et al., Acta Crystallographica A 2014, A70, C1024.
agomelatin benzensulfonate (1:1)
Methods for determination of H-atom position
a) High-quality of X-ray single crystal data
Salt: C-O(longer) – C-O(shorter) < 0,03Å ; C-O(longer)/C-O(shorter) =1,027(15) ; C-N-C > 120o
Cocrystal: C-O(longer) – C-O(shorter) > 0,08 Å ; C-O(longer)/C-O(shorter) =1,081(12) ; C-N-C = 117,7-118,5o
b) Undirect determination of H-atom position: X-ray diffraction (from bond lenghts C-O and angles O-C-O)
![Page 33: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/33.jpg)
zolpidem base
zolpidem cation
tartrate anion
bis-methanol
solvate
Čejka J., Jegorov A., Kratochvíl B. : Internal report, Teva (2007).
Ionic cocrystal – example from Teva
cocrystal zolpidem hydrogentartrate : zolpidem base bis-methanol solvate (1:1:2)
33
![Page 34: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/34.jpg)
15N ssNMR spektra různých pevných forem agomelatinu
Korelace mezi SXRD a 15N ssNMR výsledky v rozlišení solí a kokrystalů.
Resolution of salts and co-crystals by ssNMR method for agomelatin
sůl (k. benzensulfonová)
kokrystal
(k. citronová.)
polymorf I
polymorf II
sůl (k. sírová)
sůl (k. fosforečná)
sůl (k. methansulfonová)
sůl (k. chlorovodíková)
sůl (k. bromovodíková)
Kokrystaly
Soli
Převzato z dizertační prezentace ing. E. Skořepové, PhD. (2016)
If X-ray single crystal data are not available, the ssNMR
method can yield a reliable estimate
34
![Page 35: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/35.jpg)
How cocrystals are held tohether – cocrystal design
Chemical bonds between host (active molecule) and guest (coformer) in cocrystals are mostly H-bonds, Host-guest adducts are connected mostly via - interactions or VdW forces).
Theory of supramolecular synthons of the host-guest bond
Homosynthon Heterosynthoncarboxyl---carboxyl carboxyl---pyridine
A cocrystal is essentially a molecular crystal that breaks down (dissolves) into its covalent components (active molecule + coformer) in the digestive tract
35
![Page 36: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/36.jpg)
Homo- and heterosynthon types
Furcated H-bonds
More than 120 different homo- and heterosynthons are described in Cambridge Structural Database*. Heterosynthons are energetic better ones, but result of competition of number of synthons during cocrystal forming is difficult to predict
* The Cambridge Structural Database (CSD)https://www.ccdc.cam.ac.uk/solutions/csd-system/components/csd/
36
Homosynthons (a,b), heterosynthons (c,d,e)
![Page 37: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/37.jpg)
π-π Interaction as intermolecular bond in cocrystals
Common interaction in molecular crystals with aromatic systems
Examples of the
face–to-face
π-π interaction 37
![Page 38: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/38.jpg)
cocrystallization or recrystallization ?
The synthesis of new cocrystals is affected by many variables, which are mostly affected by the nature of solvent and the reactants. the stoichiometric ratio of the coformer and API, temperature, stirring, pH, and type of glassware are just a few of the effective parameters. On the other hand, the rules of hydrogen bonding, synthons, and graph sets could be helpful in designing cocrystal systems. However, there is no guarantee for cocrystal formation. Thus, preparation of cocrystals is often a multistage and empiric process.Unfortunately, we do not know all details of the co-crystallization process and the all details of the chemical bonds in cocrystals !
Cocrystal prediction
38Maryam Karimi-Jafari, Luis Padrela, Gavin M. Walker, Denise M. Croker:Crystal Growth & Design 18(10), 6370-6387 (2018).
![Page 39: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/39.jpg)
39
How to estimate the co-crystallization potential of various active molecules?
Trospium chloride
(spasmolyticum)
Alaptide
(dermatologicum)
Agomelatin
(antidepresivum)
![Page 40: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/40.jpg)
40
How to estimate the co-crystallization potential of various active molecules?
Trospium chloride Alaptide Agomelatin
10 cocrystals prepared No cocrystal 3 cocrystal prepared
Unfortunately, the co-crystallization potential of the active molecule cannot be predicted in advance
![Page 41: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/41.jpg)
41
Piroxicam (an anti-inflammatory substance)
3 polymorphs, 1 hydrate, 3 solvates, about 50 cocrystals,
7 polymorphs, about 50 cocrystals, amorphous phase
Indomethacin (a nonsteroidal anti-inflammatory substance)
Some active molecules form about 50 cocrystals
About 50 cocrystallization partners (caboxylic acids, amides or alcohols as coformers) are approved as safe for pharmacy (GRAS)
![Page 42: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/42.jpg)
Vliv různých efektů na výsledek kokrystalizace
N
NN
N
O
O
Friščic' T.: Mechanochemical approaches for the construction and discovery of API cocrystals. 24. EuropeanCrystallographic Meeting. Marrakech 2007.
Efekt methylové skupiny výchozí aktivní molekuly na uspořádání kokrystalu
theofylin
nebo +
pKa= 2,5pKa= 3,6
N
NN
NH
O
O
Kokrystal theofylin : k.šťavelová (2:1)nekonečný řetězec
kofein
Kokrystal kofein : k.šťavelová (2:1)izolovaný útvar
k. šťavelová
pKa= 8,8
42
![Page 43: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/43.jpg)
Cocrystallization formers (coformers)
1. Carboxylic acids:
adipic a., benzoic a., fumaric a., salicylic a., malonic a., adipic a., glutaric a., caprylic a. citric a., succinic a. etc.
2. Amides:
nicotinamide, isonicotinamide, urea, saccharine, etc.
3. Alcoholes:
manitole, sorbitole, xylitole, etc.
See FDA directives: GRAS (Generally Recognized as Safe) and US EAFUS ("Everything" Added to Food in the United States).
About 50 cocrystallization partners is approved as safe for pharmacy
43
![Page 44: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/44.jpg)
Predikční výběr koformerůZvolený přístup: Tvar a polarita
• Statistické hodnocení existujících
kokrystalůa
– Cambridgeská strukturní databáze
– cca. 1000 struktur
• „Podobné s podobným“
– Korelace nalezena pouze pro některé
parametry
– Polarita, tvar
• Testováno v roce 2012b
– Synthonový přístup:
• Testováno 218 koformerů,
nalezeno 48 kokrystalů
– Komplementární přístup:
• Počet experimentů snížen o 50%
• Úspěšnost zvýšena z 22% na
37%
Distribuce polarit molekulárních
párů v existujících kokrystalech
Určení molekulárních tvarových parametrů L
MS
Míra úspěšnosti nalezení
kokrystalů
a Fabian, L., Cryst Growth. Des, 2009, 9, 1446-1463.b Fabian, et al., Pharmaceutical salts and co-crystals, 2012, 89-109
Převzato z dizertační prezentace ing. E. Skořepové, PhD. (2016)44
![Page 45: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/45.jpg)
Predikční výběr koformerůPraktické provedení
Finální pořadí
Koformer
Farmaceut.
přijatelnost
Výpočet ΔpKAKyselina/
Báze/
NeutrálníΔpKA
Polarita
CCFs Velikost
CCFs
Rozdíl v
polaritě
Tvarové
parametry
CCFs
Rozdíl ve
tvaru
Nalezené
kokrystaly
CCF skóre
CCF skóre
s vlivem
farm. přij.
pKA (API)
Polarita
API
Velikost API
Tvarové
parametry
API
Převzato z dizertační prezentace ing. E. Skořepové, PhD. 45
![Page 46: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/46.jpg)
Δ pKA = pKA(base) - pKA(acid)
Δ pKA = -0,94 - (-7,0) = 6,06Agomelatin + HCl
Δ pKA = -0,94 - (13,9) = -14,84Agomelatin + Urea
Cocrystal
Salt
Δ pKA = -0,94 - (-1,1) = 0,16Agomelatin + Benzensulf. a.
??? = continuum salt…cocrystal
(H-atom is situated strictly between O and N atoms,
so it is shared)
1,25 Å 1,25 Å
O – H – N
An empirical prediction: Δ pKA rule
vzorek ΔpKa SXRD Sůl/KK ss-NMR Sůl/KK
agomelatin-isonikotinamid -15,34 Ano2 KK Ano KK
agomelatin-ethylen glykol -14,97 Ano1 KK Ne
agomelatin-močovina -14,84 Ano2 KK Ne
agomelatin-hydrochinon -11,14 Ano KK Ano KK
agomelatin-methyl-4-hydroxybenzoát -9,12 Ano2 KK Ne
agomelatin-kys. octová -5,63 Ano1 KK Ne
agomelatin-kys. 4-hydroxybenzoová -5,41 Ano KK Ano KK
agomelatin-kys. gallová -5,17 Ne Ne
agomelatin-kys. glutarová -5,17 Ne Ne
agomelatin-kys. glykolová -4,31 Ano2 KK Ne
agomelatin-kys. gensitová -3,85 Ne Ne
agomelatin-kys. citronová -3,59 Ano KK Ano KK
agomelatin-kys. malonová -3,54 Ne Ne
agomelatin-kys. maleinová -3,08 Ano KK Ne
agomelatin-kys. fosforečná -2,90 Ano Sůl Ano Sůl
agomelatin-kys. ketoglutarová -2,78 Ne Ne
agomelatin-kys. šťavelová -1,78 Ano KK Ano KK
agomelatin-kys. benzensulfonová 0,16 Ano Sůl Ano Sůl
agomelatin-kys. methansulfonová 1,48 Ano Sůl Ano Sůl
agomelatin-kys. methansulfonová (hyd.) 1,48 Ano Sůl Ne
agomelatin-kys. p-toulensulfonová 2,36 Ne Ne
agomelatin-kys. sírová 2,56 Ano Sůl Ano Sůl
agomelatin-kys. chlorovodíková 6,06 Ne Ano Sůl
agomelatin-kys.bromovodíková 7,06 Ano Sůl Ano Sůl
agomelatin-kyselina jodovodíková (2:3) 9,36 Ano Sůl Ano Sůl
agomelatin-kys.jodovodíková (1:2) 9,36 Ano Sůl Ano Sůl
agomelatin-kys. jodovodíková (1:1) 9,36 Ano Sůl Ano Sůl
Zheng S.-L., et al. Crystal Growth & Design 11, 466-471 (2011).Yan, Y., et al. Crystal Growth & Design 12, 2226–2233 (2012).
Childs S.L et al.: J. Amer. Chem. Soc. 126, 13335 (2004).
46
![Page 47: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/47.jpg)
Preparation of cocrystals - classical cocrystallization techniques
Spontaneous cocrystallization
Solution evaporation (with solvent)
Solid-state co-grinding (without solvent orwith solvent)
Co-sublimation (without solvent)
Co-melting (without solvent)
Co-heating (without solvent)
Unfortunately, almost all cocrystals which could be prepared by simple classical techniques are already described. The universal cocrystallization strategy does not exist ! 47
?
![Page 48: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/48.jpg)
48
The application of the η-parameter to predicte cocrystallization methodologies
Friščic T, Childs SL, Rizvi SAA, Jones W.: CrystEngComm 11(3):418-426 (2009).
On the basis of the parameter η we can classify those methods, from neat grinding, where
η is equal to zero, through liquid-assisted grinding (η = 0.2-12 mg ml-1), suspensions (η = 2
to 12 mg ml-1) to cocrystallizations from solutions (η >> 0). By this approach, the methods
differ mainly in the amount of solvent and the saturation ratio of the input substances.
![Page 49: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/49.jpg)
49
Spontaneous cocrystallization ?
The spontaneous cocrystallization has been reported after mixing of pure active substances and coformer under a controlled atmospheric environment, when no mechanical forces were applied
Eg. Spontaneous cocrystallization of isoniazid : benzoic a. was observed -Sarcevica, I.; Orola, L.; Nartowski, K. P.; Khimyak, Y. Z.; Round, A. N.; Fabian, L. : Mol. Pharmaceutics 2015, 12 (8), 2981– 2992.
The spontaneous cocrystallization rate can be accelerated by premilling of reagents, by drops of solvent, by temperatureand by air moisture
isoniazid, isonikotinylhydrazid (INH, antibiotic) benzoic acid
![Page 50: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/50.jpg)
Solution evaporation(at fixed temperature and pressure)
Phase diagram is symmetrical –cocrystallization components have thesame solubility.
Cocrystallization is possible !
Cocrystallization components must have similar solubility
Phase diagram is non-symmetrical –cocrystallization components do not have the same solubility.
Cocrystallization is complicated !
50
Modifications: evaporation at elevated temperature or elevated pressure, cocrystallization by cooling, cocrystallization by precipitation, reactioncocrystallization …
![Page 51: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/51.jpg)
51
Experimental and theoretical phase diagrams
Benčo T., Sládková V., Kratochvíl B.: Chem. Listy111, 829-834 (2017).
TCL – trospium chlorideSA – salicylic acid
![Page 52: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/52.jpg)
Cocrystallization screening on microfluid chips
Combinatorial cocrystallizationscreening by solution technique
240 µg of API + cocrystal former(partner)
Chip wells is resistant to organicsolvents
Analysis on-chip via Ramanspectroscopy in situ
Used in early development
Tested on model API: caffeine, which crystallizes well
Goyal, S.; Thorson, M. R. et al: Cryst. Growth Des. 12, 6023 (2012).
52
![Page 53: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/53.jpg)
Co-grinding
Stoichiometric physical mixtures (active substance + coformer) are milled under defined conditions
Retsch mixer mill : time 90 min frequency 25 Hz temperature not allowed to exceed 37 °C
The formation of an amorphous intermediate is the most likely mechanism of cocrystal formation under the cryogenic conditions
Co-grinding under the cryogenic conditions (under liquid N2)
The cocrystallizationprocess may take place via a liquid or amorphous phase, problem: incompleteconversion
Cocrystals prepared by co-grinding: 9-methyladenine + 1-methylthymine, dinitrobenzoic acids + anthracene, nicotinamide + suberic acid, carbamazepine + nicotinamide, etc.
53
![Page 54: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/54.jpg)
O
OH O
OH
OOH
N N
Liquid-assisted co-grinding (LAG)
Effect of „molecular lubricant“ during the co-grinding
cyclohexantricarboxylic a. bipyridine
liquid-assisted grinding(with several drops ofMeOH)
grinding
Partial conversion to cocrystal(1:1) after 1 hr
Complete conversion to cocrystal(1:1) after 20 min
Shan N., Toda F., Jones W.: Chem. Commun. 20, 2372 (2002).
54
![Page 55: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/55.jpg)
55
Mechanochemical co-crystallization mechanism during grinding
There is no general theory of the co-crystallization mechanism
![Page 56: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/56.jpg)
Co-melting
Při způsobu smíšené fúze se jedna složka roztaví a nechá se ztuhnout,
než se s ní dostane další roztavená složka, čímž se rozpustí část první
složky. Jakmile je veškerý materiál rekrystalizován, vytvoří se směšovací
zóna. Tato zóna představuje binární fázový diagram pro dvě složky,
přičemž jedna strana směšovací zóny představuje 100% jedné složky a
druhá strana 100% druhé složky s gradientem koncentrace napříč zónou
56
![Page 57: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/57.jpg)
57
Co-melting, an example
Snímek přípravy kokrystalu salicylová k. : nikotinamid společným tavením pomocí mikroskopie s vyhřívaným stolkemFáze: A – salicylová kyselina, B – kokrystal, C – nikotinamid
Berry D. J.; Seaton C. C.; Clegg W.; Harrington R. W.; Coles S. J.; Horton P. N.;Hursthouse M. B.; Storey R.; Jones W.; Friščić T.; Blagden N.: Cryst. Growth Des. 8, 1697 (2008).
![Page 58: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/58.jpg)
58
Co-sublimation
From literature: cocrystal urea : succinic a. (2:1) From our laboratory (Dr. Čejka)
Single cocrystal caffeine : malic a.
![Page 59: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/59.jpg)
59
Co-heatingThe co-heating method works at temperatures below the melting point of both the active ingredient and the coformer and below the eutectic melting point of the mixture. The most important parameter is the optimization of co-heating temperature and then time.
Maroušková A.: Příprava kokrystalů metodou společného zahřívání. Diplomová práce VŠCHT Praha 2017.
KOF – diklofenakHBA – hydroxybenzoová k.KOF – kofeinGLUT – glutamová k.MALO - malonová k.ŠŤAV – šťavelová k.SALI – salicylová k.BIPY – bipyridinNIKO – nikotinamidUREA – močovinaTHEO – theofylinTCL – trospium chlorid
![Page 60: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/60.jpg)
Cocrystallization by extrusion techniques
Cocrystallization from suspensions
Cocrystallization from supercritical fluids
Spray-drying cocrystallization
Freeze-drying cocrystallization
Cocrystallization by laser irradiation
Electrochemically induced cocrystallization
Sonococrystallization
Cocrystallization from gels, ionic liquids, polymers, etc.
Preparation of cocrystals – advanced techniques
60
![Page 61: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/61.jpg)
61
Cocrystallization by extrusion techniques
Twin Screw Extrusion (TSE) operates at temperatures below the melting point of cocrystallization partners
Carbamazepine:saccharin, theophylline:citric acid, caffeine:oxalic acid, and nicotinamide:cinnamic acid cocrystals were prepared by TSE(Daurio, D.; Medina, C.; Saw, R.; Nagapudi, K.; Alvarez-Núñez, F. : Pharmaceutics 2011, 3 (3), 582– 600).
Hot melt extrusion (HME) combines simultaneous melting and mixing of the cocrystallization partners via the use of a heated screw extruder
+ heaters Carbamazepine and trans-cinnamic acid cocrystal was prepared by HME ( Moradiya, H. G.; Islam, M. T.; Halsey, S.; Maniruzzaman, M.; Chowdhry, B. Z.; Snowden, M. J.; Douroumis, D. CrystEngComm 2014, 16 (17), 3573–3583).
![Page 62: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/62.jpg)
62
Isothermal slurry cocrystallization
This technique involves the suspension of the active substanceand coformer, usually in a fixed molar ratio, in a solvent with the solid fraction always remaining in excess.
Eg. cocrystals - theophylline : glutaric a. (1:1) carbamazepin : 4-aminobenzoic a.
(1:1) and (2:1); meloxicam : aspirin; toluenesulphonamide : triphenylphosphine oxide
Cocrystal conversion conditions: time, solution concentration, solvent selection
Jayasankar, A.; Reddy, L. S.; Bethune, S. J.; Rodríguez-Hornedo, N.: Cryst. Growth Des. 2009, 9 (2).Cheney, M. L.; Weyna, D. R.; Shan, N.; Hanna, M.; Wojtas, L.; Zaworotko, M. J. : J. Pharm. Sci. 2011, 100 (6), 2172– 2181. Croker, D. M.; Rasmuson, Å. C. Org. Process Res. Dev. 2014, 18 (8), 941– 946.
![Page 63: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/63.jpg)
63
Sonification of slurry
Sládková V. : Pharmaceutical cocrystals. PhD dissertation. VŠCHT Praha 2016.
Polystyrene foam rack with drilled holes for vials, floating in an ultrasonic bath, was successfully applied for cocrystallization. The method was validated on the preparation of previously known cocrystals of carbamazepine with saccharin and nicotinamide.The choice of the solvent and the residence time in the bath had the greatest influence on the preparation of cocrystals. Unlike cocrystallization in the slurry, the ultrasonic bath method allows better contact of the components even when a small amount of solvent is used and the sample is paste-like.
![Page 64: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/64.jpg)
64
Cocrystallization from supercritical fluids
The Cocrystallization with Supercritical Solvent (CSS) technique uses the solvent power of supercritical CO2 to suspend the active substance and the coformer as a slurry in liquid or supercritical CO2, avoiding the use of toxic organic solvents.Techniques used: Rapid Expansion of Supercritical Solvents (RESS) Supercritical Antisolvent Cocrystallization Supercritical CO2-Assisted Spray Drying
E.g. Cocrystallization of indomethacin, theophylline, carbamazepine, caffeine,
sulfamethazine, and acetylsalicylic acid with saccharin were reported
Cocrystal conversion conditions: effect of stirring
Neurohr, C.; Marchivie, M.; Lecomte, S.; Cartigny, Y.; Couvrat, N.; Sanselme, M.; Subra-Paternault, P. Naproxen–Nicotinamide Cocrystals: Racemic and Conglomerate Structures Generated by CO2 Antisolvent Crystallization. Cryst. Growth Des. 2015, 15 (9), 4616– 4626.
![Page 65: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/65.jpg)
65
Amorphous cocrystals ?
Properties of amorphous phases:
higher dissolution rate (faster onset of action , improved bioavailability )
higher chemical instability (higher molecular mobility, shorter expiration)
higher physical instability (the tendency for phase transition to a crystalline phase)
technological problems in manufacture ( eg., the need of the protective atmosphere )
Amorphous co-crystals have not yet been reported, but they certainly exist !
![Page 66: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/66.jpg)
66
Cocrystal analytics
single crystalCocrystallization from solution
(co-sublimation, co-melting)
Cocrystallization by co-grinding
(and other techniques) microcrystalline powder
Single crystal: one pure phase crystal structure analysis, stoichiometry
Powder: one pure phase
Powder: phase mixture phase analysis (degree of conversion to cocrystal)
crystal structure analysis, stoichiometry
The most widely used technique for the cocrystal analysis is X-ray powder diffraction (and IR, Raman
spectroscopies, ssNMR spectroscopy)
![Page 67: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/67.jpg)
input – single crystal
Determination of the crystal structure by the X-ray single crystal diffraction
X-ray diffraction
patterns
distribution of electron density
visualization by molecular graphics
(xyz) =(1/V) Fhkl exp [-2i (hx + ky + lz)]
direct methodscharge flipping
h k l
Fourier synthesis
67
X-ray diffractometer
![Page 68: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/68.jpg)
68
X-ray single crystal diffraction study of the cocrystal trospium chloride : salycilic acid (1:1)
Sládková V. : Pharmaceutical cocrystals. PhD dissertation. VŠCHT Praha 2016.
![Page 69: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/69.jpg)
69
X-ray powder diffraction study of the cocrystal synthesis by co-heating
Červeně: fyzikální směs SALI + NIKO (1:1)B. t. SALI 158,6 °CB. t. NIKO 128°C
Zeleně: vzorky po zahřívání fyzikální směsi:(1) 80o C(2) 100o C(3) 120o C
Fialově: kokrystalSALI:NIKO (1:1)(porovnání s literaturou)
Maroušková A.: Příprava kokrystalů metodou společného zahřívání. Diplomová práce VŠCHT Praha 2017.
![Page 70: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/70.jpg)
Study of crystal and molecular structure - from powder X-ray diffraction data (non-standard technique)
Methylergometrine maleate
N+H
HN
HCH3
CH
O
NH
C
CH2CH3
CH2OH
H
COO-
COOH
X-ray powder data
structure, DOF = 20
The structure from powder data is less accurate than from single crystal and moreover, the solution is limited by DOF (Degrees of Freedom) ≈ 40, but the primary
cocrystallization product is the powder
DOF parameters
70
![Page 71: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/71.jpg)
Pure phase or mixture ? One phase : after indexing all peaks !
Miller indices
Pure phase or phase mixture ? - indexation
a) When powder data indexing is successful - very likely one phaseb) When powder data indexing is unsuccessful - very likely a phase mixture
71
![Page 72: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/72.jpg)
Rietveld fit
The final Rietveld plot of the ivabradine hydrochloride (S) :mandelic acid (1:1)cocrystal, showing the measured and the calculated data. The calculated Bragg positions are shown by vertical bars.
Sládková V. : Pharmaceutical cocrystals. PhD dissertation. VŠCHT Praha 2016.
72
![Page 73: Structure and polymorphism of solid pharmaceutical substances](https://reader031.fdocuments.in/reader031/viewer/2022012020/6168881fd394e9041f704c83/html5/thumbnails/73.jpg)
Conclusions
Cocrystals offer many variations how to improve physicochemical properties of APIs(e.g., solubility, bioavailability, physical stability)
Cocrystals currently have the greatest potential for further development of API portfolio
Cocrystals open up new possibilities in patenting intellectual property and reviewing existing patent protection of APIs and dosage forms
73
Srinivasulu Aitipamula et al.:
Polymorphs, Salts, and Cocrystals: What’s in a Name?
Crystal Growth & Design. 12, 2147 (2012).